<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-148768</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevalence of silent cerebrovascular lesions in patients with obstructive sleep apnea syndrome</dc:title>
<dc:description xml:lang="en">Introduction. The obstructive sleep apnea syndrome (OSA) confers increased risk of cardiovascular disease, given its association with other vascular risk factors. Both OSA and other vascular risk factors are associated with silent brain lesions. Aim. To assess the prevalence of silent brain lesions in patients with OSA. Patients and methods. We retrospectively evaluated a cohort of 137 patients with OSA. The mean age was 65 ± 12 years; 45% were women. The silent brain lesions in magnetic resonance imaging were assessed with the Visual Scale of Fazekas (FVS), and the presence of cortical infarcts, lacunar and microbleedings was assessed. Results. Vascular risk factors prevalence was: hypertension 64%, dyslipemia 58%, diabetes 18%, smoking 34%, carotid atherosclerosis 26%, coronary heart disease 13%, and atrial fibrillation 4%. OSA was mild in 47%, moderate in 31% and severe in 22% of the patients. 91% of patients had periventricular hyperintensities, and 66% showed subcortical white matter lesions. The average value of apnea/hipopnea index was higher in patients with score 2 and 3 in FVS, although without statistical significance. Conclusions. Patients with OSA in our study have a high prevalence of silent brain lesions, mainly with microangiopathic pattern. This is possibly explained by the relation between OSA, hypertension and other vascular risk factors (AU)</dc:description>
<dc:creator>Luzzi, Ariel A</dc:creator>
<dc:creator>Balian, Natalia R</dc:creator>
<dc:creator>Pigretti, Santiago G</dc:creator>
<dc:creator>Colla Machado, Pedro E</dc:creator>
<dc:creator>Zurrú Ganen, M Cristina</dc:creator>
<dc:creator>Cristiano, Edgardo</dc:creator>
<dc:creator>Valiensi, Stella M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. El síndrome de apnea/hipopnea obstructiva del sueño (SAHOS) confiere mayor riesgo de enfermedad cardiovascular, dada su asociación con otros factores de riesgo vascular. Tanto el SAHOS como otros factores de riesgo vascular se asocian con lesiones cerebrales silentes. Objetivo. Evaluar la prevalencia de lesiones cerebrales silentes en pacientes con SAHOS. Pacientes y métodos. Se evaluó retrospectivamente una cohorte de 137 pacientes con SAHOS, con una edad media de 65 ± 12 años, el 45% mujeres. Las lesiones cerebrales silentes en resonancia magnética se evaluaron con la escala visual de Fazekas, y se consignó la presencia de infartos corticales, lacunares y microsangrados. Resultados. La prevalencia de factores de riesgo vascular fue: hipertensión, 64%; dislipidemia, 58%; diabetes, 18%; tabaquismo, 34%; ateromatosis carotídea, 26%; enfermedad coronaria, 13%; y fibrilación auricular, 4%. El SAHOS fue leve en el 47%, moderado en el 31% y grave en el 22% de los casos. El 91% de los pacientes tenía hiperintensidades periventriculares y el 66% presentaba lesiones en la sustancia blanca subcortical. El valor medio del índice de apnea/hipopnea fue mayor en los pacientes con mayor carga de lesiones, aunque sin significación estadística. Conclusiones. Los pacientes con SAHOS presentan una elevada prevalencia de lesiones cerebrales silentes, fundamentalmente con un patrón microangiopático. Posiblemente esto se explique por la asociación entre el SAHOS, la hipertensión arterial y otros factores de riesgo vascular (AU)</dc:description>
<dc:source>Rev Neurol;62(3): 113-117, 1 feb., 2016. tab</dc:source>
<dc:identifier>ibc-148768</dc:identifier>
<dc:title xml:lang="es">Prevalencia de lesión vascular cerebral silente en pacientes con síndrome de apnea/hipopnea obstructiva del sueño</dc:title>
<dc:subject>^d28620</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d2600^s22012</dc:subject>
<dc:subject>^d2600^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d2359^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d34202^s22012</dc:subject>
<dc:subject>^d2600^s29166</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d34253^s29166</dc:subject>
<dc:subject>^d2359^s22054</dc:subject>
<dc:subject>^d30611^s22074</dc:subject>
<dc:subject>^d22935^s22074</dc:subject>
<dc:subject>^d23405^s22045</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d34202^s22080</dc:subject>
<dc:subject>^d34253^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201602</dc:date>
</metadata>
</record>
</ibecs-document>
